Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,411 | 21,197 | 7,706 | 6,691 | 11,702 |
| Marketable Securities | 16,705 | 14,057 | 33,774 | 40,162 | 15,329 |
| Receivables | 19 | 96 | N/A | 209 | 100 |
| Other current assets | 0 | 0 | 186 | 20 | 176 |
| TOTAL | $30,164 | $36,490 | $42,274 | $48,573 | $28,303 |
| Non-Current Assets | |||||
| PPE Net | 90 | 59 | 64 | 69 | 75 |
| Other Non-Current Assets | 221 | 221 | 741 | 221 | 292 |
| TOTAL | $311 | $280 | $805 | $290 | $367 |
| Total Assets | $30,475 | $36,770 | $43,079 | $48,863 | $28,670 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,041 | 1,262 | 509 | N/A | 1,450 |
| Accounts payable and accrued liabilities | 1,345 | 1,850 | 1,081 | 780 | 1,750 |
| Accrued Expenses | 2,897 | 2,735 | 3,336 | 4,017 | 3,164 |
| Other current liabilities | 1,259 | 900 | 1,220 | 1,356 | 2,181 |
| TOTAL | $7,542 | $6,747 | $6,146 | $6,153 | $8,545 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,496 | 8,159 | 8,799 | 9,198 | 2,429 |
| Other Non-Current Liabilities | 16 | 18 | 19 | 18 | 16 |
| TOTAL | $7,512 | $8,177 | $8,818 | $9,216 | $2,445 |
| Total Liabilities | $15,054 | $14,924 | $14,964 | $15,369 | $10,990 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 23,447 | 23,447 | 23,447 | 23,447 | 23,447 |
| Common Shares | 2 | 2 | 2 | 2 | 1 |
| Retained earnings | -410,128 | -403,136 | -396,288 | -390,309 | -384,444 |
| Other shareholders' equity | -5 | -1 | -21 | -8 | -13 |
| TOTAL | $15,421 | $21,846 | $28,115 | $33,494 | $17,680 |
| Total Liabilities And Equity | $30,475 | $36,770 | $43,079 | $48,863 | $28,670 |